JPS5315370A - Heterocyclic compound - Google Patents

Heterocyclic compound

Info

Publication number
JPS5315370A
JPS5315370A JP9132477A JP9132477A JPS5315370A JP S5315370 A JPS5315370 A JP S5315370A JP 9132477 A JP9132477 A JP 9132477A JP 9132477 A JP9132477 A JP 9132477A JP S5315370 A JPS5315370 A JP S5315370A
Authority
JP
Japan
Prior art keywords
heterocyclic compound
heterocyclic
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP9132477A
Other languages
English (en)
Japanese (ja)
Inventor
Jiyon Deyuranto Gurahamu
Robin Ganerin Chiyaaron
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Smith Kline and French Laboratories Ltd
Original Assignee
Smith Kline and French Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smith Kline and French Laboratories Ltd filed Critical Smith Kline and French Laboratories Ltd
Publication of JPS5315370A publication Critical patent/JPS5315370A/ja
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/74Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/61Halogen atoms or nitro radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/26Radicals substituted by sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Pyridine Compounds (AREA)
JP9132477A 1976-07-28 1977-07-28 Heterocyclic compound Pending JPS5315370A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB3139176 1976-07-28

Publications (1)

Publication Number Publication Date
JPS5315370A true JPS5315370A (en) 1978-02-13

Family

ID=10322405

Family Applications (1)

Application Number Title Priority Date Filing Date
JP9132477A Pending JPS5315370A (en) 1976-07-28 1977-07-28 Heterocyclic compound

Country Status (15)

Country Link
JP (1) JPS5315370A (nl)
AU (1) AU2734677A (nl)
BE (1) BE857218A (nl)
CA (1) CA1070315A (nl)
DE (1) DE2733953A1 (nl)
DK (1) DK331877A (nl)
ES (1) ES461100A2 (nl)
FI (1) FI772293A (nl)
FR (1) FR2359840A1 (nl)
IL (1) IL52544A0 (nl)
LU (1) LU77845A1 (nl)
NL (1) NL7708375A (nl)
NO (1) NO772668L (nl)
PL (1) PL107847B1 (nl)
ZA (1) ZA774552B (nl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4309435A (en) * 1978-10-16 1982-01-05 Imperial Chemical Industries Ltd. Antisecretory guanidine derivatives and pharmaceutical compositions containing them
FR2446829A1 (fr) 1978-11-16 1980-08-14 Glaxo Group Ltd Derives de polymethylene disubstitues en alpha, omega, procede pour leur preparation et compositions pharmaceutiques les contenant
JPS57102852A (en) * 1980-12-19 1982-06-26 Shionogi & Co Ltd Dicarboxylic acid diamide
EP4196793A1 (en) 2020-08-11 2023-06-21 Université de Strasbourg H2 blockers targeting liver macrophages for the prevention and treatment of liver disease and cancer

Also Published As

Publication number Publication date
DE2733953A1 (de) 1978-02-02
CA1070315A (en) 1980-01-22
IL52544A0 (en) 1977-10-31
PL199908A1 (pl) 1978-11-20
AU2734677A (en) 1979-02-01
FR2359840A1 (fr) 1978-02-24
PL107847B1 (pl) 1980-03-31
FI772293A (nl) 1978-01-29
NO772668L (no) 1978-01-31
BE857218A (fr) 1978-01-27
LU77845A1 (nl) 1977-10-25
NL7708375A (nl) 1978-01-31
ZA774552B (en) 1978-06-28
ES461100A2 (es) 1978-12-01
DK331877A (da) 1978-01-29

Similar Documents

Publication Publication Date Title
EG13149A (en) Heterocyclic compounds
JPS52151348A (en) Compound
ZA771381B (en) Heterocyclic compounds
JPS5363424A (en) Bitumious compound
JPS52151168A (en) Heterocyclic compound
JPS52125197A (en) Transshexahydroopyridooindole compound
ZA771963B (en) Heterocyclic compounds
JPS52136170A (en) Heterocyclic compound
JPS5353618A (en) Nnsubstituted biscarbamoylsulfide compound
JPS5359686A (en) Compound
JPS5325537A (en) Compound
JPS5337653A (en) 111deoxyy111oxaprostaglandin compound
JPS5295689A (en) Betaalactummcontaining compound
JPS55127390A (en) Aryltrifluoroethylamine compound
ZA774154B (en) Heterocyclic compounds
JPS5293772A (en) Indolinospiropyran compound
ZA777535B (en) Heterocyclic compounds
JPS5323995A (en) Antiibacterial compound
JPS5321222A (en) Bissbenzoxazolyl compound
JPS5315371A (en) Heterocyclic compound
JPS5315383A (en) Heterocyclic compound
JPS5353692A (en) Antiiworm compound
JPS5315370A (en) Heterocyclic compound
JPS55102588A (en) Tetraselenapentalene compound
ZA776857B (en) Heterocyclic compounds